ABBV
$ABBV
AbbVie Inc.
Biopharmaceutical company known for Humira, Skyrizi, and Rinvoq immunology drugs.
Healthcare$200.50
-4.62 (-2.25%)
Day Range$199.81 - $205.99
Prev Close$205.12
Analyst Rating
Strong Buy
28 Buy / 11 Hold / 0 Sell
Subscribers
0
Tracking this ticker
Next Report
—
Weekly updates
Latest Report
ABBV: Pipeline strength vs. tariff and valuation risk
AbbVie ($ABBV) balances a strong dermatology pipeline and steady dividend with near-term risks from proposed drug tariffs and stretched trailing valuation. Analysts remain bullish, but key catalysts this quarter will determine direction.
Apr 6, 2026